-
Something wrong with this record ?
Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial
J. Skoda, A. Arya, F. Garcia, E. Gerstenfeld, F. Marchlinski, G. Hindricks, J. Miller, J. Petru, L. Sediva, Q. Sha, M. Janotka, M. Chovanec, P. Waldauf, P. Neuzil, VY. Reddy,
Language English Country United States
Document type Journal Article, Multicenter Study
NLK
CINAHL Plus with Full Text (EBSCOhost)
from 1990-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 1990-02-01 to 1 year ago
PubMed
26969220
DOI
10.1111/jce.12910
Knihovny.cz E-resources
- MeSH
- Internationality * MeSH
- Catheter Ablation methods MeSH
- Cohort Studies MeSH
- Tachycardia, Ventricular diagnosis surgery MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Phenomena * MeSH
- Follow-Up Studies MeSH
- Prospective Studies MeSH
- Robotic Surgical Procedures methods MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
INTRODUCTION: Catheter ablation is an effective treatment of scar-related ventricular tachycardia (VT), but the overall complexity of the procedure has precluded its widespread use. Remote magnetic navigation (RMN) has been shown to facilitate cardiac mapping and ablation of VT in a retrospective series. STOP-VT is the first multicenter, prospective, single-arm and single-procedure study evaluating RMN-based mapping and ablation of post-infarction VT. METHODS: Patients with documented VT and prior MI, in whom an ICD was implanted either for primary or secondary prevention, were recruited from four EU and US centers. Either a transseptal (48 patients) or transaortic (5 patients) approach was employed to gain access for ventricular endocardial mapping/ablation during VT (entrainment mapping, activation mapping) and/or substrate mapping in sinus rhythm (elimination of fractionated/late potentials, variable extent of substrate modification) with RMN and irrigated RF ablation. The primary endpoints were as follows: (i) non-inducibility of the target VT or any other sustained VT; (ii) elimination of sustained VT/VF during ICD follow-up of up to 12 months. RESULTS: The cohort included 53 consecutive patients (median age 67 years, 49 men, median LVEF 31%). One hemodynamically unstable patient was excluded at the onset of mapping. Inducibility of sustained VT was achieved an average of 2.2 times per patient (1-8), with mean tachycardia cycle length (TCL) 374 milliseconds (179-510). Mean total procedure and fluoroscopy times were 223 minutes and 8.7 minutes, respectively; mean cumulative fluoroscopy time during mapping and ablation was 0.95 minutes; maximum power averaged 42.3 W with nominal saline 30 cc/min irrigation; mean cumulative RF time was 38 minutes. Non-inducibility of the target VT was achieved in 49/52 patients (94.2%) and non-inducibility of any VT was achieved in 38/52 patients (73.1%). A combination of RMN and manual ablation was performed in two patients, rendering one non-inducible. During the 12-month ICD follow-up period, freedom from any sustained VT/VF was observed in 30 patients (62%), of which 19 (63%) were off antiarrhythmic medications. Five patients expired during follow-up: one presented with a VT storm, but for the others, death was not related to VT/VF (MI-cardiogenic shock, pulmonary embolism, bronchogenic carcinoma, end stage heart failure). No procedural complications were reported. CONCLUSIONS: This first prospective, single-procedure, multicenter study indicates that remote magnetic navigation is a safe and effective method for catheter ablation of post-infarction VT.
Cardiology Department Na Homolce Hospital Prague Czech Republic
Heart Center University of Leipzig Germany
Indiana University Health Bloomington Indiana USA
Mount Sinai Medical Center New York New York USA
School of Medicine University of Pennsylvania Philadephia Pennsylvania USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000351
- 003
- CZ-PrNML
- 005
- 20170118113655.0
- 007
- ta
- 008
- 170103s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jce.12910 $2 doi
- 024 7_
- $a 10.1111/jce.12910 $2 doi
- 035 __
- $a (PubMed)26969220
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Skoda, Jan $u Cardiology Department, Na Homolce Hospital, Prague, Czech Republic.
- 245 10
- $a Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial / $c J. Skoda, A. Arya, F. Garcia, E. Gerstenfeld, F. Marchlinski, G. Hindricks, J. Miller, J. Petru, L. Sediva, Q. Sha, M. Janotka, M. Chovanec, P. Waldauf, P. Neuzil, VY. Reddy,
- 520 9_
- $a INTRODUCTION: Catheter ablation is an effective treatment of scar-related ventricular tachycardia (VT), but the overall complexity of the procedure has precluded its widespread use. Remote magnetic navigation (RMN) has been shown to facilitate cardiac mapping and ablation of VT in a retrospective series. STOP-VT is the first multicenter, prospective, single-arm and single-procedure study evaluating RMN-based mapping and ablation of post-infarction VT. METHODS: Patients with documented VT and prior MI, in whom an ICD was implanted either for primary or secondary prevention, were recruited from four EU and US centers. Either a transseptal (48 patients) or transaortic (5 patients) approach was employed to gain access for ventricular endocardial mapping/ablation during VT (entrainment mapping, activation mapping) and/or substrate mapping in sinus rhythm (elimination of fractionated/late potentials, variable extent of substrate modification) with RMN and irrigated RF ablation. The primary endpoints were as follows: (i) non-inducibility of the target VT or any other sustained VT; (ii) elimination of sustained VT/VF during ICD follow-up of up to 12 months. RESULTS: The cohort included 53 consecutive patients (median age 67 years, 49 men, median LVEF 31%). One hemodynamically unstable patient was excluded at the onset of mapping. Inducibility of sustained VT was achieved an average of 2.2 times per patient (1-8), with mean tachycardia cycle length (TCL) 374 milliseconds (179-510). Mean total procedure and fluoroscopy times were 223 minutes and 8.7 minutes, respectively; mean cumulative fluoroscopy time during mapping and ablation was 0.95 minutes; maximum power averaged 42.3 W with nominal saline 30 cc/min irrigation; mean cumulative RF time was 38 minutes. Non-inducibility of the target VT was achieved in 49/52 patients (94.2%) and non-inducibility of any VT was achieved in 38/52 patients (73.1%). A combination of RMN and manual ablation was performed in two patients, rendering one non-inducible. During the 12-month ICD follow-up period, freedom from any sustained VT/VF was observed in 30 patients (62%), of which 19 (63%) were off antiarrhythmic medications. Five patients expired during follow-up: one presented with a VT storm, but for the others, death was not related to VT/VF (MI-cardiogenic shock, pulmonary embolism, bronchogenic carcinoma, end stage heart failure). No procedural complications were reported. CONCLUSIONS: This first prospective, single-procedure, multicenter study indicates that remote magnetic navigation is a safe and effective method for catheter ablation of post-infarction VT.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a katetrizační ablace $x metody $7 D017115
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a internacionalita $7 D038622
- 650 12
- $a magnetické jevy $7 D060328
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a roboticky asistované výkony $x metody $7 D065287
- 650 _2
- $a komorová tachykardie $x diagnóza $x chirurgie $7 D017180
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Arya, Arash $u Heart Center, University of Leipzig, Germany. $7 gn_A_00009120
- 700 1_
- $a Garcia, Fermin $u School of Medicine, University of Pennsylvania, Philadephia, Pennsylvania, USA.
- 700 1_
- $a Gerstenfeld, Edward $u University of California San Francisco, California, USA.
- 700 1_
- $a Marchlinski, Francis $u School of Medicine, University of Pennsylvania, Philadephia, Pennsylvania, USA.
- 700 1_
- $a Hindricks, Gerhard $u Heart Center, University of Leipzig, Germany.
- 700 1_
- $a Miller, John $u Indiana University Health, Bloomington, Indiana, USA.
- 700 1_
- $a Petru, Jan $u Cardiology Department, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Sediva, Lucie $u Cardiology Department, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Sha, Qun $u Stereotaxis, Inc, St. Louis, MO, USA.
- 700 1_
- $a Janotka, Marek $u Cardiology Department, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Chovanec, Milan $u Cardiology Department, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Waldauf, Petr $u Cardiology Department, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Neuzil, Petr $u Cardiology Department, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Reddy, Vivek Y $u Mount Sinai Medical Center, New York, New York, USA.
- 773 0_
- $w MED00002569 $t Journal of cardiovascular electrophysiology $x 1540-8167 $g Roč. 27 Suppl 1, č. - (2016), s. S29-37
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26969220 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170118113801 $b ABA008
- 999 __
- $a ok $b bmc $g 1179491 $s 960918
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 27 Suppl 1 $c - $d S29-37 $i 1540-8167 $m Journal of cardiovascular electrophysiology $n J Cardiovasc Electrophysiol $x MED00002569
- LZP __
- $a Pubmed-20170103